Seeking Alpha logoSeeking Alpha — News Tracking and Analysis

Seeking Alpha is a Website. It is based in United States of America. It covers Business news. Its media bias rating is lean right. Real Narrative News tracks and rates Seeking Alpha for bias and reliability.

Seeking Alpha is ranked #87 in Business with a score of 5.5 on the Media Scale Index.

Recent headlines from Seeking Alpha include: "IRPC Public Company Limited 2026 Q2 - Results - Earnings Call Presentation"; "ZhongAn Online P & C Insurance Co., Ltd. 2026 Q2 - Results - Earnings Call Presentation"; "NVIDIA Q2 Earnings And Outlook Matter More This Time - Here's Why"; "Weekly Closed-End Fund Roundup: FCT Reorganization, XFLT Approves New Sub-Advisor (Aug. 16, 2026)"; "Bitmine Immersion: Amid Crypto's Comeback, The Charts Point To Big Upside (Upgrade)". We track 3742 articles from this source.

Latest Articles from Seeking Alpha

Seeking Alpha - Latest News Tracking & Analysis


Latest News Politics , Business , Finance , Technology , World News & Opinion & Tracking & Analysis.

United States of America
Website
🇺🇸 english
Business
#87
Seeking Alpha

Seeking Alpha

Primary focus: Business


Recent Reportage

Latest coverage from Seeking Alpha

IRPC Public Company Limited 2026 Q2 - Results - Earnings Call Presentation

12 hours ago

ZhongAn Online P & C Insurance Co., Ltd. 2026 Q2 - Results - Earnings Call Presentation

12 hours ago

NVIDIA Q2 Earnings And Outlook Matter More This Time - Here's Why

12 hours ago

Publishing Activity

Daily article output trend

Weekly Closed-End Fund Roundup: FCT Reorganization, XFLT Approves New Sub-Advisor (Aug. 16, 2026)

12 hours ago

Bitmine Immersion: Amid Crypto's Comeback, The Charts Point To Big Upside (Upgrade)

12 hours ago

Lazard International Quality Growth Portfolio Q2 2026 Commentary

12 hours ago

Cheapest AI Infrastructure Play Left: Crypto Miners Converting To AI Data Centers

12 hours ago

CoreWeave: Why Nvidia's Price Hikes Could Be Good News - Buy Under $90

12 hours ago

Fiserv: Potential Asset Sales, Activists, And Clover Outweigh Missteps

12 hours ago

Immatics: 'Buy' On Anzu-Cel 1st Half 2027 Catalyst And Potential Label Expansion For Uveal Melanoma

12 hours ago